Serum leucine‐rich alpha‐2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy‐naïve cases with ulcerative colitis

BACKGROUND AND AIM: Serum leucine‐rich alpha‐2 glycoprotein level has been reported to be a useful biomarker in assessing mucosal healing in patients undergoing biotherapy, where mucosal lesions caused by ulcerative colitis are difficult to assess endoscopically. However, no such reports have been r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kono, Masashi, Komeda, Yoriaki, Tribonias, George, Yoshida, Saki, Nomura, Kenji, Handa, Kohei, Nagai, Tomoyuki, Hagiwara, Satoru, Omoto, Shunsuke, Takenaka, Mamoru, Nishida, Naoshi, Tsuji, Naoko, Kashida, Hiroshi, Kudo, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463021/
https://www.ncbi.nlm.nih.gov/pubmed/37649867
http://dx.doi.org/10.1002/jgh3.12953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463021/
https://www.ncbi.nlm.nih.gov/pubmed/37649867
http://dx.doi.org/10.1002/jgh3.12953

Ejemplares similares